Ryan J. Watts, President and CEO of Denali Therapeutics Inc. (NASDAQ:DNLI), filed a Form 4 on August 14, 2026, reporting a charitable transfer of 32,220 shares of common stock on August 12, 2026.

Key Highlights

  • Charitable contribution: Ryan J. Watts transferred 32,220 shares of Denali Therapeutics common stock to a donor advised fund at a price of $0.
  • Transaction code G: The disposition was recorded under transaction code G, reflecting a gift, according to the filing.
  • Indirect holding after transaction: Following the transfer, 2,120,384 shares are beneficially owned indirectly, held of record by the Watts Family 2015 Trust dated July 7, 2015, for which Watts serves as trustee.
  • Direct holding: Watts also holds 296,833 shares directly, which the filing notes includes 184,915 unvested RSUs.
  • Role: Watts is identified in the filing as both a Director and the President and CEO of Denali Therapeutics Inc.

Ryan J. Watts Reports Charitable Share Transfer at Denali Therapeutics

According to the Form 4 filed with the SEC on August 14, 2026, Ryan J. Watts, President and CEO of Denali Therapeutics Inc., disposed of 32,220 shares of the company's common stock on August 12, 2026, via an in-kind charitable contribution to a donor advised fund. The filing describes the transaction as code "G" with a price of $0, consistent with a gift rather than a market sale.

The filing reports that following the transaction, Watts beneficially owns 2,120,384 shares indirectly. Those shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which Watts serves as trustee. Separately, the filing lists a direct holding of 296,833 shares, which the filing notes includes 184,915 unvested RSUs. No derivative securities transactions were reported in Table II.

The Form 4 was signed by Tyler Nielsen by power of attorney and dated August 14, 2026. The filing does not indicate that any checkbox was marked to indicate a transaction made pursuant to a Rule 10b5-1(c) plan, nor does it indicate the form is an amendment to a prior filing.

What Was Disclosed

Watts filed a Form 4 reporting a charitable gift of 32,220 common shares to a donor advised fund on August 12, 2026, at $0. After the transaction, he indirectly holds 2,120,384 shares through a family trust and directly holds 296,833 shares, including 184,915 unvested RSUs.